210 related articles for article (PubMed ID: 15878228)
1. An European inter-laboratory validation of alternative endpoints of the murine local lymph node assay: 2nd round.
Ehling G; Hecht M; Heusener A; Huesler J; Gamer AO; van Loveren H; Maurer T; Riecke K; Ullmann L; Ulrich P; Vandebriel R; Vohr HW
Toxicology; 2005 Aug; 212(1):69-79. PubMed ID: 15878228
[TBL] [Abstract][Full Text] [Related]
2. An European inter-laboratory validation of alternative endpoints of the murine local lymph node assay: first round.
Ehling G; Hecht M; Heusener A; Huesler J; Gamer AO; van Loveren H; Maurer T; Riecke K; Ullmann L; Ulrich P; Vandebriel R; Vohr HW
Toxicology; 2005 Aug; 212(1):60-8. PubMed ID: 15950356
[TBL] [Abstract][Full Text] [Related]
3. Local lymph node assay (LLNA) for detection of sensitization capacity of chemicals.
Gerberick GF; Ryan CA; Dearman RJ; Kimber I
Methods; 2007 Jan; 41(1):54-60. PubMed ID: 16938465
[TBL] [Abstract][Full Text] [Related]
4. Assessment of the skin sensitization potency of eugenol and its dimers using a non-radioisotopic modification of the local lymph node assay.
Takeyoshi M; Noda S; Yamazaki S; Kakishima H; Yamasaki K; Kimber I
J Appl Toxicol; 2004; 24(1):77-81. PubMed ID: 14745850
[TBL] [Abstract][Full Text] [Related]
5. ICCVAM evaluation of the murine local lymph node assay. Conclusions and recommendations of an independent scientific peer review panel.
Dean JH; Twerdok LE; Tice RR; Sailstad DM; Hattan DG; Stokes WS
Regul Toxicol Pharmacol; 2001 Dec; 34(3):258-73. PubMed ID: 11754530
[TBL] [Abstract][Full Text] [Related]
6. Use of an ex vivo local lymph node assay to assess contact hypersensitivity potential.
Piccotti JR; Kawabata TT
J Immunotoxicol; 2008 Jul; 5(3):271-7. PubMed ID: 18830887
[TBL] [Abstract][Full Text] [Related]
7. The local lymph node assay being too sensitive?
Hans-Werner V; Jürgen AH
Arch Toxicol; 2005 Dec; 79(12):721-8. PubMed ID: 16025312
[TBL] [Abstract][Full Text] [Related]
8. Inter-laboratory validation of the modified murine local lymph node assay based on 5-bromo-2'-deoxyuridine incorporation.
Kojima H; Takeyoshi M; Sozu T; Awogi T; Arima K; Idehara K; Ikarashi Y; Kanazawa Y; Maki E; Omori T; Yuasa A; Yoshimura I
J Appl Toxicol; 2011 Jan; 31(1):63-74. PubMed ID: 20677212
[TBL] [Abstract][Full Text] [Related]
9. Potency values from the local lymph node assay: application to classification, labelling and risk assessment.
Loveless SE; Api AM; Crevel RW; Debruyne E; Gamer A; Jowsey IR; Kern P; Kimber I; Lea L; Lloyd P; Mehmood Z; Steiling W; Veenstra G; Woolhiser M; Hennes C
Regul Toxicol Pharmacol; 2010 Feb; 56(1):54-66. PubMed ID: 19733604
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of auricular lymph node cell lymphocyte proliferation and cytokine production as non-radioactive endpoints during murine contact allergy.
Ulker OC; Atak A; Ates I; Karakaya A
J Immunotoxicol; 2011 Jun; 8(2):131-9. PubMed ID: 21275877
[TBL] [Abstract][Full Text] [Related]
11. The local lymph node assay and skin sensitization testing.
Kimber I; Dearman RJ
Methods Mol Biol; 2010; 598():221-31. PubMed ID: 19967517
[TBL] [Abstract][Full Text] [Related]
12. Contact allergenic potency: correlation of human and local lymph node assay data.
Gerberick GF; Robinson MK; Ryan CA; Dearman RJ; Kimber I; Basketter DA; Wright Z; Marks JG
Am J Contact Dermat; 2001 Sep; 12(3):156-61. PubMed ID: 11526521
[TBL] [Abstract][Full Text] [Related]
13. Novel approach for classifying chemicals according to skin sensitizing potency by non-radioisotopic modification of the local lymph node assay.
Takeyoshi M; Iida K; Shiraishi K; Hoshuyama S
J Appl Toxicol; 2005; 25(2):129-34. PubMed ID: 15744759
[TBL] [Abstract][Full Text] [Related]
14. Characterization and evaluation of a modified local lymph node assay using ATP content as a non-radio isotopic endpoint.
Idehara K; Yamagishi G; Yamashita K; Ito M
J Pharmacol Toxicol Methods; 2008; 58(1):1-10. PubMed ID: 18462956
[TBL] [Abstract][Full Text] [Related]
15. Intralaboratory validation of alternative endpoints in the murine local lymph node assay for the identification of contact allergic potential: primary ear skin irritation and ear-draining lymph node hyperplasia induced by topical chemicals.
Ulrich P; Streich J; Suter W
Arch Toxicol; 2001 Feb; 74(12):733-44. PubMed ID: 11305775
[TBL] [Abstract][Full Text] [Related]
16. Intracellular expression of cytokines and granzyme B in auricular lymph nodes draining skin exposed to irritants and sensitizers.
Ku HO; Jeong SH; Kang HG; Pyo HM; Cho JH; Son SW; Kim HR; Lee KJ; Ryu DY
Toxicology; 2008 Sep; 250(2-3):116-23. PubMed ID: 18652873
[TBL] [Abstract][Full Text] [Related]
17. Increased cell proliferation in spleen and lymph nodes peripheral to contact allergen application site.
Chipinda I; Anderson SE; Butterworth LF; Beezhold D; Siegel PD
Toxicology; 2009 Mar; 257(3):113-6. PubMed ID: 19150643
[TBL] [Abstract][Full Text] [Related]
18. Local lymph node assay: validation assessment for regulatory purposes.
Gerberick GF; Ryan CA; Kimber I; Dearman RJ; Lea LJ; Basketter DA
Am J Contact Dermat; 2000 Mar; 11(1):3-18. PubMed ID: 10684384
[TBL] [Abstract][Full Text] [Related]
19. Qualitative and quantitative evaluation of a local lymph node assay based on ex vivo interleukin-2 production.
Azam P; Peiffer JL; Ourlin JC; Bonnet PA; Tissier MH; Vian L; Fabre I
Toxicology; 2005 Jan; 206(2):285-98. PubMed ID: 15588920
[TBL] [Abstract][Full Text] [Related]
20. A nonradioisotopic endpoint for measurement of lymph node cell proliferation in a murine allergic contact dermatitis model, using bromodeoxyuridine immunohistochemistry.
Lee JK; Park JH; Park SH; Kim HS; Oh HY
J Pharmacol Toxicol Methods; 2002; 48(1):53-61. PubMed ID: 12750042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
